AR059710A1 - Arilsulfonamidas sustituidas - Google Patents
Arilsulfonamidas sustituidasInfo
- Publication number
- AR059710A1 AR059710A1 ARP070100858A ARP070100858A AR059710A1 AR 059710 A1 AR059710 A1 AR 059710A1 AR P070100858 A ARP070100858 A AR P070100858A AR P070100858 A ARP070100858 A AR P070100858A AR 059710 A1 AR059710 A1 AR 059710A1
- Authority
- AR
- Argentina
- Prior art keywords
- halogen
- represents hydrogen
- hydrogen
- arilsulphonamids
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Arilsulfonamidas, proceso para su preparacion y su utilizacion para la produccion de medicamentos para el tratamiento y/o la profilaxis de enfermedades, especialmente para su utilizacion como agentes antivirales, particularmente contra los citomegalovirus. Reivindicacion 1: Compuesto caracterizado porque responde a la formula (1) donde A representa un grupo de formulas (2) donde * es el sitio de union con el átomo de carbono del anillo piridinilo y es el sitio de union con el átomo de carbono del anillo fenilo, R1 representa hidrogeno, amino o metilcarbonilamino, R2 representa hidrogeno o halogeno, R3 representa hidrogeno, halogeno o ciano, R4 representa hidrogeno, halogeno o ciano, R5 representa hidrogeno, o halogeno, R6 representa hidrogeno, o halogeno, R7 hidrogeno, halogeno o alquilo C1-3, R8 representa hidrogeno, halogeno o alquilo C1-3, o una de sus sales, sus solvatos o los solvatos de sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006009928A DE102006009928A1 (de) | 2006-03-03 | 2006-03-03 | Substituierte Arylsulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059710A1 true AR059710A1 (es) | 2008-04-23 |
Family
ID=38180640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070100858A AR059710A1 (es) | 2006-03-03 | 2007-03-02 | Arilsulfonamidas sustituidas |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8318761B2 (es) |
| EP (1) | EP1991529B1 (es) |
| JP (1) | JP5255455B2 (es) |
| KR (1) | KR101447758B1 (es) |
| CN (1) | CN101389607B (es) |
| AR (1) | AR059710A1 (es) |
| AT (1) | ATE451356T1 (es) |
| AU (1) | AU2007222689B2 (es) |
| BR (1) | BRPI0707068A2 (es) |
| CA (1) | CA2642602C (es) |
| DE (2) | DE102006009928A1 (es) |
| DK (1) | DK1991529T3 (es) |
| ES (1) | ES2335316T3 (es) |
| HK (1) | HK1125371A1 (es) |
| IL (1) | IL193449A (es) |
| JO (1) | JO2581B1 (es) |
| MX (1) | MX2008011264A (es) |
| PE (1) | PE20080136A1 (es) |
| PL (1) | PL1991529T3 (es) |
| PT (1) | PT1991529E (es) |
| RU (1) | RU2423352C2 (es) |
| TW (1) | TWI388559B (es) |
| UA (1) | UA95103C2 (es) |
| UY (1) | UY30178A1 (es) |
| WO (1) | WO2007101573A1 (es) |
| ZA (1) | ZA200807189B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10319612A1 (de) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituierte Dihydrochinazoline |
| EP2103317A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medizinische Geräte mit hydrophilen Beschichtungen |
| EP2103318A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medizinische Geräte mit hydrophilen Beschichtungen |
| EP2103316A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophile Polyurethandispersionen |
| EP2103638A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophile Polyurethanlösungen |
| DE102008025614A1 (de) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophile Polyurethanbeschichtungen |
| DE102008025613A1 (de) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophile Polyurethanbeschichtungen |
| AU2009289831A1 (en) | 2008-09-04 | 2010-03-11 | Bayer Materialscience Ag | TCD based hydrophilic polyurethane dispersions |
| DE102011101446A1 (de) * | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
| EP2853532B1 (en) * | 2013-09-28 | 2020-12-09 | Instytut Farmakologii Polskiej Akademii Nauk | 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III |
| CN109879817B (zh) * | 2019-03-19 | 2020-10-02 | 扬州大学 | 甲基二磺隆的制备方法 |
| RU2738848C1 (ru) * | 2019-10-24 | 2020-12-17 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
| WO2000063194A1 (fr) | 1999-04-19 | 2000-10-26 | Shionogi & Co., Ltd. | Derives de sulfonamide possedant des noyaux oxadiazole |
| DE19920790A1 (de) * | 1999-05-06 | 2000-11-09 | Bayer Ag | Bis-Sulfonamide mit anti-HCMV-Wirkung |
| DE19930075A1 (de) | 1999-06-30 | 2001-01-04 | Bayer Ag | Neue Amino- und Amidosulfonamide als antivirale Mittel |
| ES2252455T3 (es) * | 2001-04-19 | 2006-05-16 | Bayer Healthcare Ag | Arilsulfonamidas como agentes antivirales. |
| DE10138578A1 (de) | 2001-08-06 | 2003-02-27 | Bayer Ag | Heterocyclylarylsulfonamide |
-
2006
- 2006-03-03 DE DE102006009928A patent/DE102006009928A1/de not_active Withdrawn
-
2007
- 2007-02-26 PT PT07722932T patent/PT1991529E/pt unknown
- 2007-02-26 AT AT07722932T patent/ATE451356T1/de active
- 2007-02-26 CA CA2642602A patent/CA2642602C/en active Active
- 2007-02-26 PL PL07722932T patent/PL1991529T3/pl unknown
- 2007-02-26 BR BRPI0707068-3A patent/BRPI0707068A2/pt not_active Application Discontinuation
- 2007-02-26 AU AU2007222689A patent/AU2007222689B2/en not_active Ceased
- 2007-02-26 ES ES07722932T patent/ES2335316T3/es active Active
- 2007-02-26 DE DE502007002264T patent/DE502007002264D1/de active Active
- 2007-02-26 CN CN2007800066327A patent/CN101389607B/zh not_active Expired - Fee Related
- 2007-02-26 JP JP2008557628A patent/JP5255455B2/ja not_active Expired - Fee Related
- 2007-02-26 WO PCT/EP2007/001620 patent/WO2007101573A1/de active Application Filing
- 2007-02-26 EP EP07722932A patent/EP1991529B1/de active Active
- 2007-02-26 UA UAA200811582A patent/UA95103C2/ru unknown
- 2007-02-26 DK DK07722932.6T patent/DK1991529T3/da active
- 2007-02-26 MX MX2008011264A patent/MX2008011264A/es active IP Right Grant
- 2007-02-26 RU RU2008139195/04A patent/RU2423352C2/ru active
- 2007-02-26 KR KR1020087024156A patent/KR101447758B1/ko active IP Right Grant
- 2007-02-28 UY UY30178A patent/UY30178A1/es active IP Right Grant
- 2007-03-01 JO JO200762A patent/JO2581B1/en active
- 2007-03-02 TW TW096107166A patent/TWI388559B/zh not_active IP Right Cessation
- 2007-03-02 AR ARP070100858A patent/AR059710A1/es not_active Application Discontinuation
- 2007-03-02 PE PE2007000224A patent/PE20080136A1/es active IP Right Grant
-
2008
- 2008-08-14 IL IL193449A patent/IL193449A/en active IP Right Grant
- 2008-08-20 ZA ZA2008/07189A patent/ZA200807189B/en unknown
- 2008-09-03 US US12/203,793 patent/US8318761B2/en not_active Expired - Fee Related
-
2009
- 2009-05-05 HK HK09104156.3A patent/HK1125371A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR059710A1 (es) | Arilsulfonamidas sustituidas | |
| UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
| AR085586A1 (es) | Derivados de acido 3-fenilpropionico ramificados y su uso como activador de sgc | |
| AR055744A1 (es) | Derivados de acido pirimidincarboxilico, su uso para preparar medicamentos y preparacion de dicjhos compuestos | |
| PE20141598A1 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| PE20181298A1 (es) | Inhibidores de bromodominio bivalentes y usos de los mismos | |
| AR067058A1 (es) | Oxazolidinonas sustituidas y su uso para preparar medicamentos | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| NI201000107A (es) | Derivados de tiazol utilizados como inhibidores de pi 3 - cinasa. | |
| PE20151538A1 (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret) | |
| JOP20130256B1 (ar) | مركبات سلفامويل اريل اميدات واستعمالها كمواد علاجية لمعالجة التهاب الكبد نوع بي | |
| PE20160548A1 (es) | Sulfonamidas como moduladores de canales de sodio | |
| PE20140171A1 (es) | Pirazoles fungicidas y sus mezclas | |
| AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
| EA201170093A1 (ru) | Замещенные n-оксидпиразиновые производные | |
| PE20151601A1 (es) | Compuestos novedosos de pirimidina y piridina y su uso | |
| ECSP15012804A (es) | Alcoxipirazoles como activadores de guanilato ciclasa soluble | |
| AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
| PE20142282A1 (es) | Nuevos derivados de aril-quinolina | |
| UY31159A1 (es) | Derivados de quinolina, métodos para su fabricación, composiciones farmacéuticas de los mismos y usos de los mismos | |
| CO6351793A2 (es) | \"derivados de indol macrociclicos utiles como inhibidores del virus de la hepatitis | |
| AR060812A1 (es) | Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn | |
| AR081819A1 (es) | Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades | |
| AR060810A1 (es) | Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn | |
| CY1119296T1 (el) | Ενωση δικαρβοξυλικου οξεος |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |